Introduction
============

Peptic ulcer perforation (PUP) is the most common severe complication for a peptic ulcer.[@b1-ceg-4-283]--[@b3-ceg-4-283] Many studies have assessed the risk factors associated with PUP.[@b4-ceg-4-283]--[@b8-ceg-4-283] The incidence of PUP in Thailand was 10% of peptic ulcers.[@b9-ceg-4-283] PUP accounts for 5% of all abdominal emergencies.[@b1-ceg-4-283]--[@b3-ceg-4-283],[@b10-ceg-4-283] PUP is a major cause of death worldwide and continues to be a serious health problem in many hospitals in Thailand. In Nakornping Hospital (Chiang Mai), the PUP rate increased from 14.1% in 1994 to 21.9% of all peptic ulcer patients in the surgical department in 2004.[@b11-ceg-4-283] It is one of the top five conditions for hospital admissions.[@b1-ceg-4-283]--[@b3-ceg-4-283],[@b10-ceg-4-283],[@b11-ceg-4-283]

In clinical practice, patients with PUP usually present with a sudden onset of severe abdominal pain and gastrointestinal bleeding.[@b2-ceg-4-283],[@b10-ceg-4-283] Patients with PUP range from individuals who are completely asymptomatic to those who develop severe complications. Comprehensive understanding of the signs, symptoms, and pathogenesis of PUP requires an experienced medical management team with knowledge of indicators associated with PUP.

Currently, there is no gold standard for diagnosis of PUP and there is limited data regarding diagnostic indicators for early detection of PUP among patients in Thailand. The aim of this study was to determine specific diagnostic indicators of PUP based on patients' personal habits, physical examination, signs and symptoms, laboratory investigations, radiological finding, and treatment role, which would be useful for doctors and nurses in emergency or surgical departments. These indicators would establish prompt diagnosis in order to reduce PUP and risk of death from delayed treatment.[@b5-ceg-4-283],[@b7-ceg-4-283],[@b12-ceg-4-283] Diagnostic indicators of PUP are needed for early detection among patients undergoing perforation in order to improve clinical outcome.

Material and methods
====================

Inclusion criteria and diagnosis
--------------------------------

Patients aged 15 years or older who were admitted to the surgical department of Nakornping Hospital for severe abdominal pain, gastrointestinal bleeding, or hemorrhage due to gastric or duodenal ulcer perforation, and with signs and symptoms of serious bleeding or intense abdominal pain, were included in the study. Invariably, the definitive diagnosis for PUP was obtained postoperation for the patients' final diagnosis of gastric or duodenal ulcer.

Exclusion criteria
------------------

Patients with misplaced or incomplete records and patients diagnosed with perforation from malignant ulcers were excluded.

The medical records of all patients undergoing surgery for PUP from January 1, 2006 to December 31, 2009 at a tertiary care hospital in Thailand were reviewed retrospectively. The project was approved by the Ethical Review Committee for Research in Human Subjects, Chiang Mai University's Faculty of Medicine and Ethics Committee, and the Ethical Committee and/or the director of Nakornping Hospital.

Subsequently, data collection including emergency records, nurse notes, diagnostic reports, routine laboratory and radiological findings, progress notes, and operative notes were reviewed by the research nurse and attending physicians. These were obtained from patients' medical records, nurse notes, and anesthetic records. Data included patient demographics (gender and age), coexisting illnesses (diabetes mellitus, hypertension, chronic obstructive pulmonary disease, asthma, liver cirrhosis, heart disease, renal disease, and arthritis), personal habits (smoking, alcohol consumption, nonsteroidal antiinflammatory drug usage, and history of peptic ulcer), signs and symptoms (hematemesis, intense abdominal pain, tenderness, guarding, melena, systolic blood pressure, and pain onset time), laboratory investigations (hemoglobin, hematocrit, blood urea nitrogen, and creatinin), radiological finding (X-ray with free air), and treatment role (referral from other hospitals). This study period found that no patients had recurring perforations or multiple admissions.

Following review, pertinent data were recorded on preprinted data collection forms. Completed data collection forms were edited and analyzed at the study data processing center.

Definitions
-----------

PUPs included gastric ulcer perforation and duodenal ulcer perforation. Final diagnosis was determined postoperation according to the International Statistical Classification of Diseases and Related Health Problems, 10th Revision: gastric ulcer (coded K25, subcategories 25.1, 25.2, 25.5, 25.6) or duodenal ulcer (coded K26, subcategories 26.1, 26.2, 26.5, 26.6).[@b13-ceg-4-283]

Statistical analysis
--------------------

Demographic data were presented as percentage, mean, and standard deviation. All continuous data were tested for normal distribution with the Shapiro--Wilk test. Parametric tests were used based on normal distributions, and nonparametric tests were performed when assumptions were not met.

Contingency tables were constructed to analyze the relationships between PUP patients and peptic ulcer with no perforation patients. Comparison of data between the two patient groups were undertaken with Pearson's chi-square test or Fisher's exact test for categorical data and Student's t-test or Wilcoxon rank-sum test for continuous data. All variables, explored by univariable analyses, were entered into a multivariable exponential risk regression analysis to evaluate the relative risk (RR) of PUP for the diagnostic variables. Differences were considered statistically significant when *P* \< 0.05. All analyses were performed using Stata^®^ statistical software package, version 11 (StataCorp LP, College Station, TX).

Results
=======

Patient characteristics
-----------------------

During the study period, 1290 patients were included in the study; 285 patients with misplaced or incomplete records were excluded. Of included patients, 57% (740 patients) reported PUP, 58.92% (436 patients) were male, and the median age was 71 (interquartile range 14--92) years, with 69.59% (515 patients) aged ≥60 years. There were statistical differences between PUP patients and peptic ulcer with no perforation patients in coexisting illnesses (diabetes mellitus *P* \< 0.001, hypertension *P* \< 0.001, chronic obstructive pulmonary disease *P* = 0 .038, liver cirrhosis *P* \< 0.001, heart disease *P* \< 0.001, arthritis *P* = 0.032, and history of peptic ulcer *P* \< 0.001), personal habits (smoking *P* \< 0.001, alcohol consumption *P* \< 0.001, and nonsteroidal antiinflammatory drug usage *P* \< 0.001), signs and symptoms (hematemesis *P* \< 0.001, intense abdominal pain *P* \< 0.001, tenderness *P* \< 0.001, guarding *P* \< 0.001, melena *P* \< 0.001, systolic blood pressure \<100 mmHg *P* \< 0.001, and pain onset time ≥ 24 hours *P* \< 0.001), laboratory investigations (blood urea nitrogen/creatinin ratio ≥ twelvefold *P* \< 0.001), radiological finding (X-ray with free air *P* \< 0.001), and treatment role (referral from other hospitals *P* \< 0.001). In other variables, there were no statistical differences ([Table 1](#t1-ceg-4-283){ref-type="table"}).

Diagnostic indicators
---------------------

The results of univariable analyses of diagnostic indicators, including patient demographics and clinical variables from [Table 1](#t1-ceg-4-283){ref-type="table"}, in relation to PUP are presented in [Table 2](#t2-ceg-4-283){ref-type="table"}. The following variables were significantly associated with PUP in the crude analyses: male patients (RR = 1.55, 95% confidence interval \[CI\] 1.42--1.69); age ≥60 years (RR = 2.29, 95% CI 1.96--2.68); coexisting illnesses (diabetes mellitus \[RR = 1.29, 95% CI 1.07--1.55\], liver cirrhosis \[RR = 1.75, 95% CI 1.38--2.23\], heart disease \[RR = 1.27, 95% CI 1.04--1.54\], and history of peptic ulcer \[RR = 1.89, 95% CI 1.64--2.19\]); personal habits (smoking \[RR = 1.55, 95% CI 1.33--1.81\], alcohol consumption \[RR = 1.30, 95% CI 1.13--1.51\], and nonsteroidal antiinflammatory drug usage \[RR = 1.22, 95% CI 1.04--1.40\]), signs and symptoms (intense abdominal pain \[RR = 5.25, 95% CI 4.01--6.88\], tenderness \[RR = 8.87, 95% CI 6.00--13.12\], guarding \[RR = 6.57, 95% CI 5.00--8.62\], systolic blood pressure \<100 mmHg \[RR = 2.39, 95% CI 1.01--2.77\], and pain onset time ≥24 hours \[RR = 2.45, 95% CI 2.12--2.83\]); laboratory investigations (blood urea nitrogen/creatinin ratio ≥ twelvefold \[RR = 1.67, 95% CI 1.39--2.01\]); radiological finding (X-ray with free air \[RR = 7.44, 95% CI 5.81--9.51\]); and treatment role (referral from other hospitals \[RR = 3.43, 95% CI 2.62--4.49\]).

The multivariable analysis found five diagnostic indicators that were significantly related to PUP: signs and symptoms including intense abdominal pain (RR = 1.53, 95% CI 1.14--2.06), tenderness (RR = 1.94, 95% CI 1.17--3.21), and guarding (RR = 1.52, 95% CI 1.05--2.20); radiological finding of plain abdominal X-ray with free air (RR = 2.80, 95% CI 2.08--3.77); and referral from other hospitals (RR = 1.37, 95% CI 1.03--1.82) ([Table 2](#t2-ceg-4-283){ref-type="table"}).

Discussion
==========

Five diagnostic indicators, including three signs and symptoms of PUP (intense abdominal pain, tenderness, and guarding) were significantly different from peptic ulcer patients with no perforation. In the literature,[@b2-ceg-4-283] it is suggested that gastrointestinal perforation often leads to catastrophic consequences. Erosion of the gastrointestinal wall by the ulcer leads to spillage of stomach or intestinal content into the abdominal cavity. Perforation at the anterior surface of the stomach leads to the first sign which is often sudden intense abdominal pain. Posterior wall perforation leads to tenderness and guarding, which often radiates pain to the back.

A plain abdominal X-ray, which showed free air, was used in the diagnosis of PUP in the hospital setting during the study period. A previous study used fast ultrasound or computerized tomography scan to confirm diagnosis and early treatment of PUP as plain abdominal X-ray does not always prove perforation, particularly in the early stages.[@b14-ceg-4-283],[@b15-ceg-4-283] Several case series have shown that in 30%--50% of patients, the X-ray may be negative for free air, particularly in the elderly.[@b15-ceg-4-283] Unfortunately, ultrasound and computed tomography scans are limited in a developing country such as Thailand. Therefore, most cases in this study could not be confirmed by using this equipment.

In the present study, patients who were referred from other hospitals were significantly associated with PUP. No previous studies have showed this data. Health services in Thailand are mainly provided by public hospitals run by the Ministry of Public Health, university hospitals, and the private sector. Public health services include small health centers covering 3000--5500 people, 10--60 bed community hospitals covering 20,000--40,000 people, and 100--400 bed provincial hospitals covering more than 200,000 people.[@b16-ceg-4-283] A patient can visit any of these health services and then be referred to a larger hospital if the condition is serious. A number of studies concerning referral delays and secondary care delays in health care system have been previously reported.[@b17-ceg-4-283],[@b18-ceg-4-283] Data from the present study suggest that other hospital services play a very important role in determining the duration of system delay.

In summary, patient referral delays and lack of early detection of PUP in Thailand are important weaknesses with poor clinical outcomes. Severe PUP requires improved care management, avoidance of unnecessary medical treatment, and proper referral of patients. The referral system in Thailand may need revising. In addition, the findings of this study are useful for doctors and nurses in clinical practice in developing countries for early detection and treatment of PUP.

Study strengths and weaknesses
------------------------------

A strength of this study is its cohort design. The study was able to include all patients admitted to the surgical department with an accurate evaluation of patient characteristics and careful evaluation of patient records. Several diagnostic factors indicate this study to be valid: (1) large sample size of patients with PUP, (2) patient characteristics were based on real data from clinical practice, and (3) audit process was carefully planned and carried out with anonymous medical records; detailed medical records were reviewed by both surgical gastroenterologists and researchers.

A limitation of this study was the use of retrospective medical records that were sometimes incomplete. Unfortunately, it was not always possible to collect all risk factors, possibly because those filling out the documents had not accounted for a prospective study.

Conclusion
==========

High-risk patients, ie, those who are referred from other hospitals with three signs and symptoms of PUP (intense abdominal pain, tenderness, and guarding) and present plain abdominal X-ray with free air, should be concerned. Reducing diagnostic delays in the referral system, with the intention of increasing the proportion of early detection of PUP, may improve patient outcomes in Thailand.
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###### 

Baseline characteristics of peptic ulcer perforation

  Characteristics                   PUP                    PUNP    *P* value                      
  --------------------------------- ---------------------- ------- ---------------------- ------- ---------
  Gender                                                                                          
    Male                            436                    58.92   453                    82.36   \<0.001
    Female                          304                    41.08   97                     17.64   
  Age (years)                                                                                     
    \<60                            225                    30.41   420                    76.36   \<0.001
    ≥60                             515                    69.59   130                    23.64   
    Median (IQR)                    71 (14--92)                    52 (32--85)                    \<0.001
  Coexisting illnesses                                                                            
    Diabetes mellitus               141                    19.05   58                     10.55   \<0.001
    Hypertension                    132                    17.84   188                    34.08   \<0.001
    COPD                            66                     8.92    32                     5.82    0.038
    Asthma                          3                      0.41    3                      0.55    0.51
    Liver cirrhosis                 75                     10.14   3                      0.55    \<0.001
    Heart disease                   120                    16.22   51                     9.27    \<0.001
    Renal disease                   67                     90.5    62                     11.27   0.189
    Arthritis                       75                     10.14   37                     6.73    0.032
    History of peptic ulcer         398                    53.78   93                     16.91   \<0.001
  Personal habits                                                                                 
    Smoking                         513                    69.32   252                    45.82   \<0.001
    Alcohol consumption             399                    53.92   211                    38.36   \<0.001
    NSAID usage                     199                    26.89   100                    18.18   \<0.001
  Signs and symptoms                                                                              
   Hematemesis                      200                    27.03   229                    41.64   \<0.001
   Intense abdominal pain           683                    92.30   214                    38.91   \<0.001
   Tenderness                       714                    96.49   261                    47.45   \<0.001
   Guarding                         684                    92.43   155                    28.18   \<0.001
   Melena                           57                     7.70    129                    23.45   \<0.001
   Systolic blood pressure (mmHg)                                                                 
    ≥100                            303                    40.95   502                    91.27   \<0.001
    \<100                           437                    59.05   48                     8.73    
    Median (IQR)                    98 (68--162)                   119 (99--215)                  \<0.001
   Pain onset time (hours)                                                                        
    \<24                            323                    43.65   522                    94.91   \<0.001
    ≥24                             417                    56.35   28                     5.09    
    Median (IQR)                    24 (1--68)                     6 (1--47)                      \<0.001
  Laboratory finding                                                                              
    Hemoglobin (mg/dL)                                                                            
    Mean ± SD                       10.55 ± 2.26                   10.41 ± 2.52                   0.853
    Hematocrit (%)                                                                                
    ≥30                             344                    46.49   235                    42.73   0.179
    \<30                            396                    53.51   315                    57.27   
    Mean ± SD                       30.80 ± 6.81                   30.99 ± 7.83                   0.354
    BUN (mg/dL)                                                                                   
    Median (IQR)                    30.34 (3.60--213.50)           26.50 (1.00--111.80)           \<0.001
    Creatinin (mg/dL)                                                                             
    Median (IQR)                    2.48 (0.25--31.5)              1.69 (0.25--61)                \<0.001
    BUN/creatinin ratio                                                                           
    \<12                            142                    19.19   225                    40.91   \<0.001
    ≥12                             598                    80.81   325                    59.09   
  Radiological finding                                                                            
    X-ray with free air                                                                           
    No                              70                     9.46    494                    89.82   \<0.001
    Yes                             670                    90.54   56                     10.18   
  Treatment role                                                                                  
   Referral from other hospitals                                                                  
    No                              57                     7.70    230                    41.82   \<0.001
    Yes                             683                    92.30   320                    58.18   

**Abbreviations:** BUN, blood urea nitrogen; COPD, chronic obstructive pulmonary disease; IQR, interquartile range; NSAID, nonsteroidal antiinflammatory drug; PUNP, peptic ulcer with no perforation; PUP, peptic ulcer perforation.

###### 

Univariable and multivariable analysis risk ratio and 95% confidence interval of diagnostic indicators for peptic ulcer perforation

  Diagnostic indicators             Crude RR   95% CI          *P* value   Multivariable RR   95% CI         *P* value
  --------------------------------- ---------- --------------- ----------- ------------------ -------------- -----------
  Gender                                                                                                     
   Female                           1.00       Reference                                      Reference      
   Male                             1.55       (1.42--1.69)    \<0.001     1.09               (0.94--1.27)   0.263
  Age (years)                                                                                                
   \<60                             1.00       Reference                                      Reference      
   ≥60                              2.29       (1.96--2.68)    \<0.001     1.19               (0.90--1.58)   0.22
  Coexisting illnesses                                                                                       
   Diabetes mellitus                                                                                         
    No                              1.00       Reference                                      Reference      
    Yes                             1.29       (1.07--1.55)    0.006       0.97               (0.80--1.18)   0.782
   Hypertension                                                                                              
    No                              1.00       Reference                                      Reference      
    Yes                             0.66       (0.55--0.79)    \<0.001     0.93               (0.76--1.15)   0.525
   COPD                                                                                                      
    No                              1.00       Reference                                      Reference      
    Yes                             1.19       (0.93--1.53)    0.175       0.96               (0.72--1.27)   0.771
   Asthma                                                                                                    
    No                              1.00       Reference                                      Reference      
    Yes                             0.87       (0.28--2.71)    0.811       1.08               (0.32--3.61)   0.902
   Liver cirrhosis                                                                                           
    No                              1.00       Reference                                      Reference      
    Yes                             1.75       (1.38--2.23)    \<0.001     1.05               (0.82--1.34)   0.719
   Heart disease                                                                                             
    No                              1.00       Reference                                      Reference      
    Yes                             1.27       (1.04--1.54)    0.018       1.05               (0.85--1.30)   0.672
   Renal disease                                                                                             
    No                              1.00       Reference                                      Reference      
    Yes                             0.90       (0.70--1.15)    0.391       0.89               (0.69--1.17)   0.408
   Arthritis                                                                                                 
    No                              1.00       Reference                                      Reference      
    Yes                             1.19       (0.93--1.51)    0.161       1.25               (0.97--1.61)   0.090
  Personal habits                                                                                            
   Smoking                                                                                                   
    No                              1.00       Reference                                      Reference      
    Yes                             1.55       (1.33--1.81)    \<0.001     1.07               (0.87--1.31)   0.509
   Alcohol consumption                                                                                       
    No                              1.00       Reference                                      Reference      
    Yes                             1.30       (1.13--1.51)    \<0.001     1.05               (0.86--1.29)   0.605
   NSAID usage                                                                                               
    No                              1.00       Reference                                      Reference      
    Yes                             1.22       (1.04--1.40)    0.017       1.09               (0.92--1.29)   0.333
   History of peptic ulcer                                                                                   
    No                              1.00       Reference                                      Reference      
    Yes                             1.89       (1.64--2.19)    \<0.001     1.13               (0.97--1.32)   0.128
  Signs and symptoms                                                                                         
   Hematemesis                                                                                               
    No                              1.00       Reference                                      Reference      
    Yes                             0.74       (0.63--0.87)    \<0.001     0.97               (0.81--1.16)   0.716
   Intense abdominal pain                                                                                    
    No                              1.00       Reference                                      Reference      
    Yes                             5.25       (4.01--6.88)    \<0.001     1.53               (1.14--2.06)   0.005
   Tenderness                                                                                                
    No                              1.00       Reference                                      Reference      
    Yes                             8.87       (6.00--13.12)   \<0.001     1.94               (1.17--3.21)   0.010
   Guarding                                                                                                  
    No                              1.00       Reference                                      Reference      
    Yes                             6.57       (5.00--8.62)    \<0.001     1.52               (1.05--2.20)   0.026
   Melena                                                                                                    
    No                              1.00       Reference                                      Reference      
    Yes                             0.50       (0.38--0.65)    \<0.001     0.86               (0.63--1.16)   0.330
   Systolic blood pressure (mmHg)                                                                            
    ≥100                            1.00       Reference                                      Reference      
    \<100                           2.39       (1.01--2.77)    \<0.001     1.11               (0.83--1.46)   0.484
   Pain onset time (hours)                                                                                   
    \< 24                           1.00       Reference                                      Reference      
    ≥ 24                            2.45       (2.12--2.83)    \<0.001     1.22               (0.99--1.50)   0.058
  Laboratory findings                                                                                        
   Hemoglobin (g/dL)                                                                                         
    ≥ 10                            1.00       Reference                   1.00               Reference      
    \< 10                           1.01       (0.98--1.04)    0.488       1.01               (0.94--1.09)   0.720
   Hematocrit (%)                                                                                            
    ≥ 30                            1.00       Reference                   1.00               Reference      
    \< 30                           1.07       (0.92--1.23)    0.381       1.00               (0.97--1.02)   0.855
   BUN/creatinin ratio                                                                                       
    \< 12                           1.00       Reference                                      Reference      
    ≥ 12                            1.67       (1.39--2.01)    \<0.001     1.08               (0.88--1.32)   0.470
  Radiological finding                                                                                       
   X-ray with free air                                                                                       
    No                              1.00       Reference                                      Reference      
    Yes                             7.44       (5.81--9.51)    \<0.001     2.80               (2.08--3.77)   \<0.001
  Treatment roles                                                                                            
   Referral from other hospitals                                                                             
    No                              1.00       Reference                                      Reference      
    Yes                             3.43       (2.62--4.49)    \<0.001     1.37               (1.03--1.82)   0.032

**Abbreviations:** BUN, blood urea nitrogen; CI, confidence interval; COPD, chronic obstructive pulmonary disease; NSAID, nonsteroidal antiinflammatory drug; RR, relative risk.
